Random

neuropsychopharmacology

·May 20, 2022·3 min read

Novel Preclinical Drug Could Have Potential to Combat Depression, Brain Injury, and Cognitive Disorders

A preclinical drug that inhibits the kinase enzyme Cdk5 may have the potential to treat depression, brain injuries, and disorders associated with cognitive impairment.

Featured Psychology

·July 19, 2017·5 min read

Old Antibiotic Could Form New Depression Treatment

Minocycline, a broad-spectrum tetracycline antibiotic, has shown promise in the treatment of depression. Researchers say the antibiotic could help reduce brain inflammation associated with some cases of major depressive disorder. A small study conducted by researchers at Deakin University found those treated with Minocycline reported improved quality of life, reduced anxiety symptoms and a better global impression of their depression.

Featured Neuroscience Open Neuroscience Articles Psychology

·March 16, 2022·3 min read

Largest Ever Psychedelics Study Maps Changes of Conscious Awareness to Neurotransmitter Systems

Study reveals how psychedelic drug-induced changes in subjective awareness are rooted in specific neurotransmitter systems.

Featured Neuroscience Psychology

·May 15, 2017·6 min read

Psychedelics in The Lab and Clinic – Making Up For Lost Time

Used in a controlled psychotherapy setting, psychedelics have the potential to treat psychiatric treatments that do not respond to conventional medications, researchers argue.

Autism Featured Neuroscience Psychology

·April 24, 2018·4 min read

Prolonged Acetaminophen Use During Pregnancy Linked to Increased ASD and ADHD Risk

A new study reveals a link between prolonged acetaminophen use in pregnancy and an increased risk of offspring being diagnosed with ADHD or ASD. Researchers report children of mothers who had prolonged exposure to the pain killer during pregnancy had a 30% increased risk of developing ADHD and a 20% increased risk of being diagnosed with ASD.

This shows a depressed looking young man

Featured Neuroscience Psychology

·February 18, 2021·4 min read

New Information on the Effects of Antidepressants

SSRI's, ketamine, and tricyclic antidepressants all bind with TrkB. The findings challenge the roles serotonin and glutamate receptors play in the effects of antidepressant medications.

Featured Psychology

·November 17, 2017·3 min read

New Therapy Lessens Impact of Early Age Mistreatment

For male victims of childhood mistreatment, specific medications can prevent or reduce epigentic marks and improve behavior, a new study reports. However, this does not appear to be the case for females. Researchers note that the study underlies the importance of recognizing sex differences in research and treatments.

This shows Vyvanse (Lisdexamfetamine) 70mg capsules

Featured Neuroscience Psychology

·November 17, 2022·5 min read

ADHD Medication for Amphetamine Addiction Linked to Reduced Risk of Hospitalization and Death

Lisdexamfetamine (Vyvanse), a medication commonly used to treat ADHD, lowers the risk of hospitalization and death for those with amphetamine use disorder.

Image of a woman holding her head in her hands.

Featured Psychology

·November 6, 2015·4 min read

Better Options for Treatment Resistant Schizophrenia

A new study reports people with treatment resistant schizophrenia appear to have better outcomes when they are switched to clozapine rather than other antipsychotic medications.

This shows fish and the structure of NRF2

Featured Neuroscience Psychology

·April 13, 2020·2 min read

Discovery of a drug to rescue winter depression-like behavior

Fish model study found a potential target for the treatment of seasonal affective disorder (SAD). Researchers implicated NRF2 in seasonal depression and reported celastrol may help in the treatment of SAD.